LMF
EVOK

LMR Master Fund’s Evoke Pharma EVOK Stock Holding History

LMR Master Fund’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$297K Buy
+277
New +$397K 0.03% 300

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

LMR Master Fund's EVOK Position: Q4 2013 in Review

LMR Master Fund opened a new position in Evoke Pharma (EVOK) in Q4 2013: 277 shares worth $297K. The stake represents 0.03% of the portfolio and ranks #300 among its holdings.

7 funds tracked by Wall St. Rank hold EVOK as of Q4 2013.

  • LMR Master Fund held 277 shares of Evoke Pharma worth $297K as of Q4 2013.
  • Evoke Pharma was a new LMR Master Fund position in Q4 2013.
  • Evoke Pharma made up 0.03% of LMR Master Fund's portfolio in Q4 2013, its #300 holding.
  • 7 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.